MRK

2024Q1BMO

Merck & Company Inc primary · HEALTHCARE · DRUG MANUFACTURERS - GENERAL

Report 2024-04-25 · Fiscal end 2024-03-31 · Features as of 2024-04-24

← Earnings history

Pre-Earnings Data

Expectations & setup

Street

Consensus EPS1.92
Consensus rev—
EPS high—
EPS low—
Dispersion—
Analysts—
EPS rev net 7d—
EPS rev net 30d—
Consensus Δ 7d—
Consensus Δ 30d—

Options

Implied move1.2%
IV front—
P/C full—
P/C front—
Features as of2024-04-24

Run-up

Close—
Ret 5d+1.3%
Ret 10d+0.2%
Ret 20d+1.2%
Ret 30d+3.5%

Post-Earnings Data

Results & reaction

Print

Actual EPS
2.07Beat
Estimated EPS1.92
Actual revenue
15.8B
Surprise %+7.8%
Beat / missBeat
Beat streak 44
Beat streak 88

Reaction

1-day stock reaction+0.8%
Implied vs actual

Implied 1.2%Actual 2.1%

Gap reaction+2.1%
Day result+2.9%
Next-day upYes
Realized / IV1.84×

Post tape

Post 5d-1.9%
Post 10d-0.4%
Post volume12.8M
Vol ×10d1.86×
Vol ×20d1.78×
Post range3.1%